Lymphoma News

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Bioengineering company Ossium Health, which is developing the first bank of bone marrow collected from organ donors, has partnered with the National Marrow Donor Program/Be The Match to increase access to lifesaving bone marrow.

In patients with atopic dermatitis treated with dupilumab, a reversible and most likely benign lymphoid reaction could occur, according to a study.

Bayer will work with the FDA toward voluntary withdrawal of its follicular lymphoma treatment copanlisib from the U.S. market, according to a company-issued press release.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses treatment challenges in DLBCL care.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the unmet needs of patients with DLBCL.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the challenges of researching combination therapies.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the latest advancements in the treatment of DLBCL.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the latest advancements in DLBCL subtying and classification.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.